SCHD vs XNOV
Schwab US Dividend Equity ETF vs FT Vest US Equity Enhance & Moderate Buffer ETF - November
Which is better, SCHD or XNOV?
Large Cap Value against Multi Alternative.
SCHD has a lower expense ratio. SCHD led over 1Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | SCHD | XNOV |
|---|---|---|
| Expense Ratio | 0.06%Best | 0.85% |
| AUM | $112.1B | $57M |
| Dividend Yield | 3.00% | 0.00% |
| Holdings | 103 | 12 |
| YTD Return | +25.88%Best | +6.42% |
| 1Y Return | +30.22%Best | +10.52% |
| 3Y Return (annualized) | +16.05% | - |
| 5Y Return (annualized) | +10.17% | - |
| Volatility (annualized) | 12.9% | 4.2%Best |
| Max Drawdown | -16.1% | -10.0%Best |
| $10,000 over 2.8 years | $15,903Best | $13,089 |
| Fund Family | Charles Schwab Asset Management | First Trust Portfolios (US) |
| Category | Equity | Alternative |
| Style | Large Cap Value | Multi Alternative |
| Inception | Oct 20, 2011 | Nov 17, 2023 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 2.8 years row, are measured over the window both funds cover: Nov 20, 2023 to Sep 14, 2026 (2.8 years).
SCHD vs XNOV growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 2.8 years both funds cover.
SCHD vs XNOV Performance
Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management and FT Vest US Equity Enhance & Moderate Buffer ETF - November (XNOV) is an ETF from First Trust Portfolios (US). Over the past year SCHD returned +30.22% while XNOV returned +10.52%. Year to date, SCHD is up 25.88% versus a gain of 6.42% for XNOV.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
SCHD has been the more volatile fund, with annualized monthly volatility of 12.9% compared with 4.2% for XNOV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -16.1% for SCHD and -10.0% for XNOV. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.44. They move together some of the time, and apart the rest.
Fees and Cost Over Time
SCHD charges 0.06% per year while XNOV charges 0.85%. On a $10,000 position that is $6 vs $85 annually, a gap of $79 per year that compounds over a long holding period. On income, SCHD currently yields 3.00% against 0.00% for XNOV.
You are not choosing between two funds in isolation.
Whichever of SCHD and XNOV you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, SCHD or XNOV?
SCHD has an expense ratio of 0.06% while XNOV charges 0.85%. SCHD is the cheaper option, by $79 a year on a $10,000 investment.
Which performed better, SCHD or XNOV?
Over the past year SCHD returned +30.22% vs +10.52% for XNOV, so SCHD leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, SCHD or XNOV?
SCHD has been the more volatile fund at 12.9% annualized versus 4.2% for XNOV. Worst drawdown: SCHD -16.1% vs XNOV -10.0%.
Should I hold both SCHD and XNOV?
SCHD and XNOV have a monthly-return correlation of 0.44, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, SCHD or XNOV?
SCHD yields 3.00% while XNOV yields 0.00%, so SCHD currently pays the higher dividend yield.
Is XNOV better than SCHD?
SCHD has a lower expense ratio. SCHD led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.